What Happens When a Pesticide Batch Is Out of Specification?

When test results for a pesticide batch exceed approved product specifications, the first step is not to immediately scrap the batch or retest it until it meets specifications, but to suspend release, investigate the cause, and determine the final disposition based on comprehensive evidence.

In pesticide production and international procurement, these situations typically involve “Out of Specification” (OOS) results, meaning test results exceed applicable quality specifications or acceptance limits.

For pesticide importers, distributors, and brand owners, the four key questions to focus on are:

• Is this test anomaly genuine and valid?
• If the product is out of specification, what caused it?
• Can the manufacturer resolve the issue through legitimate, controlled, and technically sound means?
• Under what conditions can we accept or release this shipment?

Not all OOS results mean that the entire batch must be scrapped. However, until the issue has been properly investigated and resolved, you cannot assume the product now meets requirements based solely on a verbal explanation from the supplier or a new, compliant Certificate of Analysis (COA).

What Does an Out-of-Specification Pesticide Batch Mean?

OOS indicates that test results exceed the acceptance limits specified in the applicable Product Specification.

For example, if a batch of suspension concentrate fails the suspensibility test by falling below the approved minimum, or if a relevant impurity exceeds the specified upper limit, this may constitute an OOS.

However, note that identifying abnormal results, confirming product nonconformity, and deciding how to dispose of the entire batch are three distinct steps.

Situation	Meaning	Action to Be Taken
Missing Data	Missing required test data	Supplement or verify the data; do not consider the audit complete for the time being
OOT (Out of Trend)	Results may still be within specifications but deviate from historical trends	Determine whether an investigation is necessary based on the quality system
Initial OOS	Initial test results exceed acceptance limits	Suspend release and initiate an investigation
Confirmed OOS	After investigation, there is still sufficient evidence that the product does not meet specifications	Formally evaluate the disposition of the batch; it must not be released directly as a conforming batch

OOT typically describes deviations from established data trends, but the specific definition and handling procedures depend on the company’s quality system.

Similarly, the absence of a single test result does not necessarily mean that the item has failed testing. Purchasing personnel must distinguish between missing data, abnormal trends, and actual nonconformity to avoid premature, erroneous judgments.

If the anomaly is discovered during a pre-shipment review of the test report, please refer to our How to Audit a Pesticide Specification Against the COA Before Shipment to learn how to verify that the test results align with the approved product specifications.

What Should Happen Immediately After an OOS Result?

When an OOS result is discovered, the manufacturer must first control the risk to prevent the problematic batch from being mistakenly released before the investigation is complete.

For products that have not yet been shipped, the relevant batch should be labeled, isolated, or system-locked in accordance with quality management procedures, and its normal release should be suspended.

Subsequently, relevant personnel must retain the original test results, sample information, test records, and production batch documentation.

Specific actions can be divided into four steps:

1. Hold the Batch

Suspend the release of the batch. Do not bypass necessary quality investigations simply because an order has been paid for, a shipping deadline is approaching, or the customer urgently needs the product.

2. Preserve the Evidence

Preserve the original test data, sample numbers, test methods, equipment records, and relevant production documentation. Do not retain only subsequent pass results while ignoring the initial nonconforming records.

3. Notify the Responsible Team

Notify Quality Control, Quality Assurance, and relevant production personnel. If the nonconformity may affect the order delivery date, promptly communicate with the sales representative responsible for the order.

4. Define the Investigation Scope

Clearly define which batch and test items require investigation, and whether there is reason to suspect other related batches may also be affected.

If the product has already been shipped, further assess the actual risks, the affected shipments, and markets, and take appropriate measures in accordance with destination regulations.

The goal of this stage is not to immediately determine who should bear the loss, but to control the risk first and ensure the problem does not escalate before the investigation is complete.

How Is an Out-of-Specification Result Investigated?

An OOS investigation cannot be limited to simply retesting the product. A reasonable investigation should simultaneously consider laboratory testing, the production process, and other factors that may affect the results.

Check the Original Laboratory Result

First, verify that the original test was performed correctly in accordance with the applicable method.

The investigation may include the following areas:

• Whether the sample was representative;
• Whether sample preparation was performed correctly;
• Whether the test method and calculation procedures were appropriate;
• Whether there were any anomalies in instrument operation, calibration, and related records;
• Whether reference materials, reagents, and testing conditions met requirements;
• Whether verifiable errors occurred in data entry or calculations.

If reliable evidence confirms that a specific testing error caused the anomalous result, the original result may be evaluated and handled in accordance with applicable quality procedures.

However, the initial test result cannot be directly deemed invalid merely because the retest result is within specifications.

If no clear cause can be identified to explain the out-of-specification (OOS) result, the original result must not be arbitrarily deleted, nor should a “pass” conclusion be fabricated through selective reporting of data.

Investigate the Manufacturing Process

If the laboratory investigation cannot fully explain the OOS, the next step is to examine the manufacturing process.

For finished formulations, the following may need to be evaluated:

• Quality and batch-to-batch variations in raw materials;
• Records of ingredient preparation, weighing, and mixing;
• Whether deviations occurred in critical manufacturing parameters;
• Whether equipment operation and process execution complied with requirements;
• Whether any changes to raw materials, formulations, or production conditions occurred without proper evaluation;
• Whether similar abnormalities occurred in related batches.

The investigation direction depends on the product type and the parameters involved in the abnormality.

For example, an abnormality in Active Ingredient Content may involve a different investigation path than an abnormality in Suspensibility for an SC product; one cannot apply exactly the same cause determination to both.

Assess Whether Other Batches May Be Affected

If the investigation reveals that the anomaly may be related to shared raw materials, production equipment, manufacturing conditions, or storage environments, an assessment should be conducted to determine whether other relevant batches may also be affected.

This does not mean that all products from the same production line must automatically be deemed non-conforming.

However, if there is a reasonable risk of association, determine the investigation scope based on the evidence; it is not sufficient to address only the batch in which the problem was first detected.

For situations involving quality changes after storage, refer to Pesticide Storage Stability Data: Buyer Checklist for further information on the role of stability data in quality evaluation.

Can an Out-of-Specification Pesticide Batch Be Retested?

Retesting may be considered if it is scientifically justified and complies with applicable procedures; however, retesting is not a shortcut to turning a non-compliant result into a compliant one.

Retesting should resolve a specific technical issue, such as verifying whether a particular test result was affected by a verifiable laboratory error, or further evaluating product quality under a reasonable investigation plan.

Before deciding to retest, the following should be clarified:

• Why retesting is necessary;
• What issue the retest addresses;
• What test method will be used;
• How the sample will be obtained and handled;
• How all valid results will be recorded and evaluated;
• who is responsible for reviewing the final conclusion.

If the retest results still do not meet specifications, further evaluation is required to determine whether the issue stems from the product itself or the manufacturing process.

If the retest results meet specifications, the initial out-of-specification (OOS) result should not be automatically disregarded. The investigation must explain the discrepancy between the two sets of results and provide sufficient evidence to support the final determination.

Similarly, the number of tests should not be increased indefinitely until a single result happens to meet the requirements.

Importers should be wary of situations where a supplier simply sends a new, compliant Certificate of Analysis (COA) without explaining the original abnormal results or providing any reasonable conclusions from the investigation.

In such cases, the issue has not been truly resolved.

Can the Manufacturer Rework an Out-of-Specification Batch?

For some nonconforming batches, technically feasible corrective actions or rework solutions may exist; however, whether they can be implemented depends on the specific product, the cause of the nonconformity, applicable regulations, and quality procedures.

Rework and Retesting are not the same thing.

Retesting involves re-evaluating test results; rework involves subjecting the product itself to controlled processing.

For example, if a physical property does not meet requirements, the manufacturer may need to investigate the formulation, manufacturing process, or other relevant factors. However, it cannot be directly assumed that adjusting a specific formulation parameter will necessarily restore product quality.

Before considering rework, at least the following issues should be clarified:

Evaluation Items	Items to Confirm
Technical Feasibility	Does a reasonable, verifiable treatment plan exist?
Regulatory Compliance	Does the plan comply with applicable regulations and registration requirements?
Product Quality	Could the processing procedure affect other quality parameters?
Approved Procedure	Has it undergone appropriate technical and quality reviews?
Traceability	Can the original batch and the reworked product be fully documented?
Final Verification	Which reworked-product parameters require re-evaluation?

For pesticide formulations, the potential impact of rework on other quality attributes should also be considered.

For example, an improvement in the physical properties of an SC product does not automatically prove that its active ingredient content, other physical parameters, and storage stability all meet requirements.

If rework involves changes to the container, seals, or other packaging conditions, re-evaluate the packaging’s suitability based on the actual circumstances. Refer to Pesticide Packaging Compatibility: Why the Container Is Part of Product Quality to understand the relationship between packaging and formulation quality.

Particular attention must be paid to the following: Non-compliant results must not be masked by arbitrary mixing, dilution, or modification of specifications without sufficient technical justification and appropriate approval.

If rework is technically unfeasible or does not comply with applicable regulations and registration conditions, do not enforce it solely to meet commercial order delivery requirements.

When Should a Pesticide Batch Be Rejected?

If an investigation confirms that the product does not meet applicable specifications, and there is no legitimate, technically sound, and appropriately approved corrective action plan, rejection or other appropriate disposition must be considered.

The following situations warrant particular attention:

• The original out-of-specification results are confirmed;
• Rework is not feasible, or the relevant processing does not meet applicable requirements;
• Specifications are still not met after rework;
• Critical quality issues cannot be adequately explained;
• Compliance of the final product with applicable quality and registration requirements cannot be demonstrated;
• The supplier cannot provide sufficient batch traceability and final quality evidence.

Note that “Reject” does not necessarily mean the product must be destroyed in all cases. First, it means this batch of products cannot be accepted or released as compliant with the original requirements.

Subsequent actions should be determined based on the product’s condition, contractual agreements, regulatory requirements, and environmental disposal regulations. This may involve returns, replacements, controlled rework, or, when required by law, appropriate disposal.

Similarly, selling at a discounted price should not be used to circumvent quality or registration requirements. If a product fails to meet mandatory safety, regulatory, or registration criteria, an agreement between the buyer and seller to reduce the price does not automatically render it compliant.

What Documents Should Importers Request After an OOS Result?

For importers, the key is not to request as many documents as possible from the supplier, but to obtain sufficient evidence to support the final decision on the batch.

It is recommended to request applicable documentation from the supplier based on the nature and severity of the issue.

Documents or Records	Intended Use
Original OOS Result	Understand the initial out-of-specification (OOS) finding
Laboratory Investigation	Confirm whether there are verifiable testing issues
Root Cause Investigation	Understand the cause of the anomaly and the basis for the determination
Manufacturing Review	Verify relevant manufacturing processes and batch records
Retest Results	Review retest data and its relationship to the original results
Approved Rework Plan	If rework is involved, confirm that the plan has undergone appropriate review
Final QC Results	Evaluate whether the final product meets applicable requirements
Updated COA, Where Applicable	Record relevant test results for the final batch
CAPA Records, Where Relevant	Understand corrective and preventive actions
Batch Disposition Record	Confirm the final batch disposition and its basis

Not every routine quality deviation requires all of the above documentation.

For example, the level of investigation required for a simple data entry error may differ from that required for a confirmed manufacturing process anomaly.

The purchaser should determine a reasonable scope of evidence based on actual risks and contractual requirements.

If the supplier’s trade secrets are involved, relevant evidence may be reviewed through mutually agreed-upon methods; however, this should not result in a complete waiver of reasonable verification of critical quality issues.

Most importantly, the supplier must clearly explain: what happened, why it happened, what actions were taken, and why the final product is or is not acceptable.

What Happens If an OOS Batch Has Already Been Shipped?

If an OOS is discovered after the product has been shipped, the complexity of handling the issue typically increases, as the product may already be in transit, in the importer’s warehouse, or even out in the distribution channel.

In such cases, the issue cannot simply be deferred until the next order.

The following should be confirmed first:

• Which batches are affected;
• Where the shipment is currently located;
• Whether other batches pose the same risk;
• Whether the nonconformity could affect product safety, quality, or registration compliance;
• Whether to suspend sales, quarantine inventory, notify relevant customers, or contact local regulatory authorities.

Determine specific measures based on the actual risk, the product’s intended use, destination regulations, and contractual requirements.

If the product may pose significant safety or compliance risks, the manufacturer, importer, and relevant registration holders should promptly assess the risk and take necessary measures in accordance with applicable requirements.

Not all OOS situations should be treated as a recall, and you should not conclude that no follow-up action is required without first completing a risk assessment.

What Is the Commercial Impact on the Buyer?

In addition to product quality, OOS incidents may also affect procurement lead times, inventory planning, customer deliveries, and payment arrangements.

If the affected batch cannot be delivered as originally planned, the importer should promptly confirm:

• Whether a replacement batch can be provided on schedule;
• whether the new batch requires re-audit;
• whether relevant documentation and lot numbers need to be updated;
• whether local registration or import documentation is affected;
• how related costs and liabilities should be handled in accordance with the contract.

It is best to clarify these issues in advance in the purchase contract or quality agreement, rather than waiting until the goods cannot be shipped to begin negotiations.

How Can Manufacturers Prevent the Same OOS Problem From Happening Again?

Processing the current batch does not mean the entire quality issue has been resolved.

If you don’t investigate the cause of the out-of-specification (OOS) issue, the same problem may recur in the next batch of products.

This is where Corrective and Preventive Action (CAPA) proves its value.CAPA should be based on the investigation findings, rather than simply stating, “Strengthen quality management.”

Identified Causes	Possible Follow-Up Measures
Raw Material Variations	Evaluate incoming material quality control and consider changes to relevant suppliers
Deviations in Manufacturing Parameters	Improve process control, documentation, or operational requirements
Insufficient sample representativeness	Refine applicable sampling procedures
Issues with test method execution	Verify method execution, equipment condition, and personnel training
Quality changes caused by storage	Re-evaluate applicable stability and storage controls
Recurring issues of the same nature	Review the implementation and effectiveness of CAPA

Corrective actions should address identified issues, while preventive actions should reduce the risk of similar issues recurring.

Follow-up should also include an appropriate evaluation of whether the measures are effective.

For example, if a specific physical quality issue appears consecutively in multiple commercial batches, do not rely solely on adding an additional test before each shipment; instead, determine whether a persistent issue exists in the manufacturing process.

For importers, whether a supplier can provide a reasonable explanation for recurring quality anomalies and take effective measures to prevent their recurrence is also an important indicator of long-term supply capability.

A Practical Example: When an SC Pesticide Fails Suspensibility Testing

Suppose an importer purchased a batch of Azoxystrobin 250 g/L SC.

During pre-shipment quality testing, it was found that the suspensibility results for this batch fell below the specification requirements previously agreed upon by both parties.

The following is an illustrative example and does not represent any actual batch or POMAIS test data.

Step 1: Suspend release.

The manufacturer must identify and control the relevant batch and retain the original test results and sample records.

Step 2: Investigate the test results.

Verify the applicable test methods, sample handling, original records, and other relevant data to determine whether evidence can explain the anomaly.

Step 3: Investigate the manufacturing process.

If there is insufficient evidence to indicate that the anomaly stems from a testing error, examine the relevant raw materials, formulations, and production and storage records based on the actual circumstances.

Step 4: Evaluate Remediation Options.

If a physical quality issue is confirmed, determine whether a technically feasible remediation plan exists that complies with regulatory requirements and has been appropriately approved.

A product cannot be deemed compliant as a whole solely because the Active Ingredient Content meets the requirements.

Step 5: Verify the finished product.

If approved rework or corrective actions have been implemented, the finished product should be re-evaluated against applicable quality requirements, and the results should be fully documented.

Step 6: Make a batch decision.

Consider release only after all necessary issues have been reasonably resolved, the finished product meets applicable requirements, and the required audits are complete.

If compliance cannot be restored, the batch should be handled in accordance with applicable quality and contractual procedures.

This example shows that an OOS is not simply a “pass” or “fail” label, but a quality event that requires step-by-step judgment based on evidence.

Frequently Asked Questions

Does an OOS Result Mean the Entire Pesticide Batch Must Be Rejected?

Not necessarily. An initial OOS result requires investigation. The final decision should be based on valid test data, investigation conclusions, applicable specifications, and relevant regulations. If the nonconformity is confirmed and cannot be resolved through permitted means, the batch cannot be released directly as compliant.

Can a Manufacturer Retest a Failed Pesticide Batch?

Retesting may be considered if scientifically justified and in accordance with applicable procedures. However, you may not repeatedly retest a batch, retaining only passing results while disregarding the original nonconforming data.

Can an Out-of-Specification Batch Be Reworked?

Rework may be feasible for certain batches, but you must consider product characteristics, quality risks, applicable regulations, and registration requirements, and the rework must undergo appropriate technical and quality reviews.

Can a Supplier Change the Specification After a Failed Test?

Approved standards must not be arbitrarily relaxed after the fact solely to allow a batch to pass. Any specification change must undergo appropriate change control and must not circumvent applicable registration and regulatory requirements.

Is a New Passing COA Enough to Close an OOS Investigation?

Not necessarily. You also need to evaluate the original out-of-specification (OOS) finding, investigation results, basis for retesting, and quality evidence for the finished product based on the nature of the issue. A new Certificate of Analysis (COA) does not automatically replace a comprehensive OOS investigation.

What Should an Importer Do if the Supplier Cannot Explain the OOS Result?

The importer should request a reasonable explanation of the investigation and supporting evidence. Do not accept the batch based solely on the supplier’s verbal assurance until key issues are resolved.
If necessary, consider independent testing or other appropriate measures under the contract.

What Happens if an OOS Batch Has Already Reached the Market?

Immediately assess the nonconformity, potential risks, affected batches, and distribution scope, then determine—based on destination regulations and actual circumstances—whether to quarantine inventory, notify customers, suspend sales, or take other measures.

How Can Buyers Reduce the Risk of OOS Problems in Future Orders?

Before purchasing, clearly define product specifications, acceptance limits, and applicable testing methods, and establish procedures for sample approval, commercial batch QC, COA review, and handling quality anomalies. For repeat purchases, attention should also be paid to whether the supplier can maintain batch consistency and effectively address any issues that have arisen.

Discuss Pesticide Quality and Supply Requirements With POMAIS

For pesticide importers and distributors, a stable supply relationship depends not only on product pricing but also on whether both parties clearly define product identity, quality requirements, batch documentation, and shipping terms prior to production.

For new procurement projects, it is recommended to confirm the following in advance:

• Active Ingredient, Concentration, and Formulation;
• Target markets and applicable registration requirements;
• Approved Product Specifications;
• Applicable batch QC and COA requirements;
• Packaging, labeling, and batch traceability requirements;
• Procedures for investigating, notifying, and addressing quality deviations.

This information helps both parties clarify acceptance criteria before production begins, reducing disputes from differing interpretations of specifications, document inconsistencies, or batch quality deviations.

If you are planning a new pesticide procurement, product portfolio, or import project, you can contact POMAIS with the product name, active ingredient content, formulation, target market, expected procurement volume, and relevant technical requirements to facilitate further discussion on applicable products and supply solutions.

Core Principle: When a pesticide batch deviates from the specification, prioritize risk control before investigating the cause; you may decide whether to release the batch only after the issue has been reasonably resolved, the final quality meets applicable requirements, and the necessary audits are complete.